News Releases News Releases Year None20202019201820172016 Jan 27, 2020 Sorrento to Present Late Breaking Positive Clinical Trial Data for Resiniferatoxin at Two Prestigious Upcoming Pain Conferences Jan 10, 2020 Sorrento Therapeutics, Inc. Received Non-Binding Acquisition Proposal Jan 06, 2020 Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Tools Print Print Email Alerts Email Alerts RSS Feeds RSS Feeds Email Page Email Page
News Releases Year None20202019201820172016 Jan 27, 2020 Sorrento to Present Late Breaking Positive Clinical Trial Data for Resiniferatoxin at Two Prestigious Upcoming Pain Conferences Jan 10, 2020 Sorrento Therapeutics, Inc. Received Non-Binding Acquisition Proposal Jan 06, 2020 Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3
Jan 27, 2020 Sorrento to Present Late Breaking Positive Clinical Trial Data for Resiniferatoxin at Two Prestigious Upcoming Pain Conferences
Jan 06, 2020 Sorrento Announces Filing for Approval of Infliximab Biobetter Antibody by Its Partner Mabpharm in China
